The psoriasis (PsO) therapeutics market in Australia is dominated by biologics such as anti-TNF, anti-IL-17, anti-IL-23, and anti-IL-12/anti-IL-23 therapies. Among these, stiff competition exists among AbbVie’s Skyrizi, Novartis’ Cosentyx, Eli […]
Eli Lilly
Trending topics and news from the Eli Lilly category
Back to news homeADA 2021: Eli Lilly and Novo Nordisk will continue to compete over GLP-1RA market, says GlobalData
Eli Lilly and Novo Nordisk will continue to compete over the glucagon-like peptide 1 receptor agonist (GLP-1RA) market, with the strong possibility that the two pharmaceutical giants will completely own […]